Colin Goddard, Chief Executive Officer at OSI PHARMACEUTICALS INC (OSIP), sold 27,250 shares at $36.23 ($982K) on 2006-08-25, disclosed to the SEC on 2006-08-29.
Scheduled sale ($982k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.75 | 1,000 | $36K | 3.6% |
| 2 | $35.79 | 230 | $8K | 0.8% |
| 3 | $35.80 | 1,400 | $50K | 5.1% |
| 4 | $35.81 | 819 | $29K | 3.0% |
| 5 | $35.82 | 204 | $7K | 0.7% |
| 6 | $35.83 | 400 |
| $14K |
| 1.5% |
| 7 | $35.84 | 1,400 | $50K | 5.1% |
| 8 | $35.85 | 300 | $11K | 1.1% |
| 9 | $35.87 | 100 | $4K | 0.4% |
| 10 | $35.89 | 3,047 | $109K | 11.1% |
| 11 | $35.93 | 1,100 | $40K | 4.0% |
| 12 | $36.05 | 672 | $24K | 2.5% |
| 13 | $36.06 | 11 | $397 | 0.0% |
| 14 | $36.07 | 208 | $8K | 0.8% |
| 15 | $36.08 | 228 | $8K | 0.8% |
| 16 | $36.09 | 100 | $4K | 0.4% |
| 17 | $36.11 | 600 | $22K | 2.2% |
| 18 | $36.13 | 1,200 | $43K | 4.4% |
| 19 | $36.14 | 600 | $22K | 2.2% |
| 20 | $36.15 | 6,500 | $235K | 23.9% |
| 21 | $36.16 | 200 | $7K | 0.7% |
| 22 | $36.18 | 217 | $8K | 0.8% |
| 23 | $36.20 | 3,564 | $129K | 13.1% |
| 24 | $36.21 | 800 | $29K | 2.9% |
| 25 | $36.22 | 350 | $13K | 1.3% |
| 26 | $36.23 | 600 | $22K | 2.2% |
| 27 | $36.27 | 300 | $11K | 1.1% |
| 28 | $36.28 | 800 | $29K | 3.0% |
| 29 | $36.29 | 300 | $11K | 1.1% |
| Total | $36.05 avg | 27,250 | $982K | 100% |
| Filing → |
| OSIP | SELL | 2010-03-03 | $3.6M | — | Filing → |
| OSIP | SELL | 2007-06-06 | $1.5M | — | Filing → |
| OSIP | SELL | 2006-08-29 | $100K | — | Filing → |